EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 127 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $442,921 | -52.5% | 79,093 | -55.5% | 0.00% | – |
| Q1 2024 | $931,709 | -8.1% | 177,807 | -8.3% | 0.00% | – |
| Q4 2023 | $1,013,699 | -60.1% | 193,824 | +20.2% | 0.00% | -100.0% |
| Q3 2023 | $2,542,960 | -39.2% | 161,253 | -25.1% | 0.00% | 0.0% |
| Q2 2023 | $4,184,071 | -13.0% | 215,230 | +26.9% | 0.00% | 0.0% |
| Q1 2023 | $4,810,020 | +16.0% | 169,546 | +19.5% | 0.00% | 0.0% |
| Q4 2022 | $4,147,561 | +143018.0% | 141,894 | +29.4% | 0.00% | 0.0% |
| Q3 2022 | $2,898 | -60.6% | 109,677 | -33.8% | 0.00% | -50.0% |
| Q2 2022 | $7,357 | -99.9% | 165,582 | -7.1% | 0.00% | 0.0% |
| Q1 2022 | $8,825,000 | +60.7% | 178,306 | +65.3% | 0.00% | +100.0% |
| Q4 2021 | $5,493,000 | -8.0% | 107,868 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $5,972,000 | -29.4% | 107,076 | -45.9% | 0.00% | -50.0% |
| Q2 2021 | $8,464,000 | +47.8% | 197,762 | +44.1% | 0.00% | +100.0% |
| Q1 2021 | $5,728,000 | -17.0% | 137,222 | -7.4% | 0.00% | -50.0% |
| Q4 2020 | $6,900,000 | -2.7% | 148,169 | -11.2% | 0.00% | 0.0% |
| Q3 2020 | $7,088,000 | +21.7% | 166,866 | +37.5% | 0.00% | 0.0% |
| Q2 2020 | $5,822,000 | -61.3% | 121,343 | -62.9% | 0.00% | -60.0% |
| Q1 2020 | $15,055,000 | +81.3% | 327,293 | +136.9% | 0.01% | +150.0% |
| Q4 2019 | $8,302,000 | +116.0% | 138,173 | +103.4% | 0.00% | +100.0% |
| Q3 2019 | $3,844,000 | -35.1% | 67,940 | -36.1% | 0.00% | -50.0% |
| Q2 2019 | $5,922,000 | -10.4% | 106,352 | -18.7% | 0.00% | 0.0% |
| Q1 2019 | $6,607,000 | +0.9% | 130,860 | -19.4% | 0.00% | 0.0% |
| Q4 2018 | $6,546,000 | -43.8% | 162,457 | -3.3% | 0.00% | -33.3% |
| Q3 2018 | $11,643,000 | +28.1% | 167,934 | +39.8% | 0.00% | +50.0% |
| Q2 2018 | $9,088,000 | +68.4% | 120,115 | +17.2% | 0.00% | +100.0% |
| Q1 2018 | $5,398,000 | -9.2% | 102,444 | -7.9% | 0.00% | 0.0% |
| Q4 2017 | $5,943,000 | +11.6% | 111,257 | +24.6% | 0.00% | 0.0% |
| Q3 2017 | $5,326,000 | -38.4% | 89,306 | -18.5% | 0.00% | -50.0% |
| Q2 2017 | $8,644,000 | -32.4% | 109,581 | -28.9% | 0.00% | -33.3% |
| Q1 2017 | $12,784,000 | +270.3% | 154,137 | +254.3% | 0.00% | +200.0% |
| Q4 2016 | $3,452,000 | +56.8% | 43,501 | +38.3% | 0.00% | 0.0% |
| Q3 2016 | $2,201,000 | +102.3% | 31,446 | +12.1% | 0.00% | – |
| Q2 2016 | $1,088,000 | -76.2% | 28,050 | -75.1% | 0.00% | -100.0% |
| Q1 2016 | $4,569,000 | -25.9% | 112,812 | +62.3% | 0.00% | 0.0% |
| Q4 2015 | $6,165,000 | +1118.4% | 69,522 | +918.8% | 0.00% | – |
| Q3 2015 | $506,000 | -65.4% | 6,824 | -62.3% | 0.00% | – |
| Q2 2015 | $1,463,000 | +255.1% | 18,098 | +83.9% | 0.00% | – |
| Q1 2015 | $412,000 | – | 9,839 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |